NM_001128425.2:c.2T>C
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1
The NM_001128425.2(MUTYH):c.2T>C(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001128425.2 start_lost
Scores
Clinical Significance
Conservation
Publications
- pontocerebellar hypoplasia type 7Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001128425.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MUTYH | NM_001128425.2 | MANE Plus Clinical | c.2T>C | p.Met1? | start_lost | Exon 1 of 16 | NP_001121897.1 | ||
| TOE1 | NM_025077.4 | MANE Select | c.1A>G | p.Met1? | start_lost | Exon 1 of 8 | NP_079353.3 | ||
| MUTYH | NM_012222.3 | c.2T>C | p.Met1? | start_lost | Exon 1 of 16 | NP_036354.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MUTYH | ENST00000710952.2 | MANE Plus Clinical | c.2T>C | p.Met1? | start_lost | Exon 1 of 16 | ENSP00000518552.2 | ||
| TOE1 | ENST00000372090.6 | TSL:1 MANE Select | c.1A>G | p.Met1? | start_lost | Exon 1 of 8 | ENSP00000361162.5 | ||
| MUTYH | ENST00000372098.7 | TSL:1 | c.2T>C | p.Met1? | start_lost | Exon 1 of 16 | ENSP00000361170.3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152218Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000804 AC: 2AN: 248816 AF XY: 0.00000740 show subpopulations
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461384Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727006 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74372 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 2 Uncertain:2
This variant causes the loss of the translation initiation codon in the MUTYH protein. However, codon 15 codes for a methionine that may serve as an alternative translation initiation codon. In addition, two other alternative first exons encode alternative initiation codons. Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been performed for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has been identified in 3/280214 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
This sequence change affects the initiator methionine of the MUTYH mRNA. The next in-frame methionine is located at codon 15. This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with MUTYH-related conditions. ClinVar contains an entry for this variant (Variation ID: 230848). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Hereditary cancer-predisposing syndrome Uncertain:2
The p.M1? variant (also known as c.2T>C), located in coding exon 1 of the MUTYH gene, results from a T to C substitution at nucleotide position 2. This alters the methionine residue at the initiation codon (ATG). Variations that modify the initiation codon (ATG) are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame; however, there are in-frame methionines 15 and 54 amino acids from the initiation site, which may result in N-terminal truncation of unknown functional significance. Based on the available evidence, the clinical significance of this variant remains unclear.
This variant causes the loss of the translation initiation codon in the MUTYH protein. However, codon 15 encodes methionine, which may serve as an alternative translation initiation site. In addition, two other transcripts use different downstream initiation codons. To our knowledge, functional studies have not been performed for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has been identified in 3/280214 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Gastric cancer Pathogenic:1
not specified Uncertain:1
not provided Uncertain:1
Initiator codon variant in a gene for which a downstream in-frame ATG produces an alternate clinically-relevant isoform that may result in a functional protein (Plotz 2012); Has not been previously published as pathogenic or benign to our knowledge; Observed in 3/280214 (0.0011%) alleles in large population cohorts (Lek 2016); This variant is associated with the following publications: (PMID: 22473953)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at